SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?


To: wl9839 who wrote (188)3/22/2000 12:54:00 PM
From: Raymond Clutts  Respond to of 746
 
The consistently socialist bent of the Clinton administration denuded the pharmaceutical companies of much of their share valuation in the early 1990s, they ran Columbia/HCA out of the for profit hospital market and now they are trying to starve genome firms by denying them legal ownership of their IP work product. The HMO "patient reform" legislation that is now being enacted will serve only to end the one mechanism that can constrain cost inflation and thereby keep the provision of healthcare insurance as a benefit provided by private sector employers.

Face it, Clinton and the Democrats want a public sector monopoly on the business of providing health care coverage and services. It is not safe to invest in any healthcare related enterprise until he is out of office and the Republicans have control of Congress. Sorry, but this area has become a political football that the Democrats' demagoging periodically lets the air out of.

What was that quote from a Lutheran minister who after World War II reflected on Hitler's rise by saying (my best effort at recollection), "First they came for the Jews but I wasn't a Jew so I didn't object-then they came for the gypsys and the freemasons but I wasn't a gypsy or a freemason so I didn't object. Then they came for me and by that time there was no left to object." Clinton and the Democrats are starting this process again at the end of his administration by going after the HMOs that everyone dislikes.

The Democrats would rather socialize healthcare than face the prospect of trying to justify the efficiency and existence of the Medicare and Medicaid programs by comparison with private sector initiatives.

It's impossible to underestimate the long term damage that Clinton's done all of our generation by depriving us of the innovations from healthcare (and now biotech entrepreneurs) that might have occurred but for his persistent efforts to implement national healthcare on a piecemeal basis. If these entrepreneurs are prevented from realizing profits consistent with the benefits they've yielded to human longevity, collectively they will go elsewhere to spend their time and energy.

And we will all live poorer and shorter lives as a result.



To: wl9839 who wrote (188)3/26/2000 11:27:00 PM
From: Susan G  Respond to of 746
 
I think the simple answer is confusion

I think another simple answer for what happened is:
LOBBYISTS

The large pharmaceutical companies who are "demanding" this information be free, without realizing they cannot use the raw data spend huge amounts on lobbyists. Some of the biggest spenders I believe.